Starpharma Holdings reported AUD7.82M in Operating Expenses for its fiscal semester ending in December of 2024.


Operating Expenses Change Date
Medical Developments International AUD 19.8M 9.46M Dec/2024
Mesoblast 48.24M 21.34M Jun/2024
Neuren Pharmaceuticals AUD 17.41M 2.86M Dec/2024